Erin Weeda1,2,3, Rachael E Gilbert1,2, Shelby J Kolo1,2, Jason S Haney1,2,3, Linh Tran Hazard3, David J Taber1,2,4, Robert Neal Axon1,2,5. 1. Charleston Patient Safety Center of Inquiry, Ralph H Johnson VAMC, Charleston, SC, USA. 2. Charleston Health Equity and Rural Outreach Innovation Center, Ralph H Johnson VAMC, Charleston, SC, USA. 3. College of Pharmacy, 15472Medical University of South Carolina, Charleston, SC, USA. 4. Department of Surgery, 15472Medical University of South Carolina, Charleston, SC, USA. 5. Department of Medicine, 15472Medical University of South Carolina, Charleston, SC, USA.
Abstract
BACKGROUND: Transitions of care (ToC) aim to provide continuity while preventing loss of information that may result in poor outcomes such as hospital readmission. Readmissions not only burden patients, they also increase costs. Given the high prevalence of coronary artery diseases (CAD) in the United States (US), patients with CAD often make up a significant portion of hospital readmissions. OBJECTIVE: To conduct a systematic review evaluating the impact of pharmacist-driven ToC interventions on post-hospital outcomes for patients with CAD. METHODS: MEDLINE, Scopus, and CINAHL were searched from database inception through 03/2020 using key words for CAD and pharmacists. Studies were included if they: (1) identified adults with CAD at US hospitals, (2) evaluated pharmacist-driven ToC interventions, and (3) assessed post-discharge outcomes. Outcomes were summarized qualitatively. RESULTS: Of the 1612 citations identified, 11 met criteria for inclusion. Pharmacist-driven ToC interventions were multifaceted and frequently included medication reconciliation, medication counseling, post-discharge follow-up and initiatives to improve medication adherence. Hospital readmission and emergency room visits were numerically lower among patients receiving vs not receiving pharmacist-driven interventions, with statistically significant differences observed in 1 study. Secondary prevention measures and adherence tended to be more favorable in the pharmacist-driven intervention groups. CONCLUSION: Eleven studies of multifaceted, ToC interventions led by pharmacists were identified. Readmissions were numerically lower and secondary prevention measures and adherence were more favorable among patients receiving pharmacist-driven interventions. However, sufficiently powered studies are still required to confirm these benefits.
BACKGROUND: Transitions of care (ToC) aim to provide continuity while preventing loss of information that may result in poor outcomes such as hospital readmission. Readmissions not only burden patients, they also increase costs. Given the high prevalence of coronary artery diseases (CAD) in the United States (US), patients with CAD often make up a significant portion of hospital readmissions. OBJECTIVE: To conduct a systematic review evaluating the impact of pharmacist-driven ToC interventions on post-hospital outcomes for patients with CAD. METHODS: MEDLINE, Scopus, and CINAHL were searched from database inception through 03/2020 using key words for CAD and pharmacists. Studies were included if they: (1) identified adults with CAD at US hospitals, (2) evaluated pharmacist-driven ToC interventions, and (3) assessed post-discharge outcomes. Outcomes were summarized qualitatively. RESULTS: Of the 1612 citations identified, 11 met criteria for inclusion. Pharmacist-driven ToC interventions were multifaceted and frequently included medication reconciliation, medication counseling, post-discharge follow-up and initiatives to improve medication adherence. Hospital readmission and emergency room visits were numerically lower among patients receiving vs not receiving pharmacist-driven interventions, with statistically significant differences observed in 1 study. Secondary prevention measures and adherence tended to be more favorable in the pharmacist-driven intervention groups. CONCLUSION: Eleven studies of multifaceted, ToC interventions led by pharmacists were identified. Readmissions were numerically lower and secondary prevention measures and adherence were more favorable among patients receiving pharmacist-driven interventions. However, sufficiently powered studies are still required to confirm these benefits.
Authors: Jonathan A C Sterne; Jelena Savović; Matthew J Page; Roy G Elbers; Natalie S Blencowe; Isabelle Boutron; Christopher J Cates; Hung-Yuan Cheng; Mark S Corbett; Sandra M Eldridge; Jonathan R Emberson; Miguel A Hernán; Sally Hopewell; Asbjørn Hróbjartsson; Daniela R Junqueira; Peter Jüni; Jamie J Kirkham; Toby Lasserson; Tianjing Li; Alexandra McAleenan; Barnaby C Reeves; Sasha Shepperd; Ian Shrier; Lesley A Stewart; Kate Tilling; Ian R White; Penny F Whiting; Julian P T Higgins Journal: BMJ Date: 2019-08-28
Authors: Rachel Neu; Melvin A Leonard; Michelle L Dehoorne; Samantha J Scalia; Pramodini B Kale-Pradhan; Christopher A Giuliano Journal: Ann Pharmacother Date: 2019-10-11 Impact factor: 3.154
Authors: Sunil Kripalani; Christianne L Roumie; Anuj K Dalal; Courtney Cawthon; Alexandra Businger; Svetlana K Eden; Ayumi Shintani; Kelly Cunningham Sponsler; L Jeff Harris; Cecelia Theobald; Robert L Huang; Danielle Scheurer; Susan Hunt; Terry A Jacobson; Kimberly J Rask; Viola Vaccarino; Tejal K Gandhi; David W Bates; Mark V Williams; Jeffrey L Schnipper Journal: Ann Intern Med Date: 2012-07-03 Impact factor: 25.391
Authors: Cynthia A Jackevicius; Noelle K de Leon; Lingyun Lu; Donald S Chang; Alberta L Warner; Freny Vaghaiwalla Mody Journal: Ann Pharmacother Date: 2015-08-10 Impact factor: 3.154
Authors: Alessandro Liberati; Douglas G Altman; Jennifer Tetzlaff; Cynthia Mulrow; Peter C Gøtzsche; John P A Ioannidis; Mike Clarke; P J Devereaux; Jos Kleijnen; David Moher Journal: BMJ Date: 2009-07-21
Authors: P Michael Ho; Anne Lambert-Kerzner; Evan P Carey; Ibrahim E Fahdi; Chris L Bryson; S Dee Melnyk; Hayden B Bosworth; Tiffany Radcliff; Ryan Davis; Howard Mun; Jennifer Weaver; Casey Barnett; Anna Barón; Eric J Del Giacco Journal: JAMA Intern Med Date: 2014-02-01 Impact factor: 21.873
Authors: Karen B Farris; Barry L Carter; Yinghui Xu; Jeffrey D Dawson; Constance Shelsky; David B Weetman; Peter J Kaboli; Paul A James; Alan J Christensen; John M Brooks Journal: BMC Health Serv Res Date: 2014-09-18 Impact factor: 2.655